TG Therapeutics Inc (NAS:TGTX)
$ 16.48 -0.94 (-5.4%) Market Cap: 2.55 Bil Enterprise Value: 2.45 Bil PE Ratio: 74.91 PB Ratio: 15.91 GF Score: 75/100

TG Therapeutics Inc at Goldman Sachs Global Healthcare Conference (Virtual) Transcript

Jun 11, 2020 / 08:40PM GMT
Release Date Price: $16.8 (-5.03%)
Graig Suvannavejh;Michael S. Weiss
Goldman Sachs Group Inc., Research Division - Executive Director & Senior Equity Research Analyst;TG Therapeutics, Inc. - Executive Chairman, CEO & President

Good -- great. Good afternoon, everyone, and welcome to the 4:40 p.m. session at Day 3 of the Goldman Sachs Global Healthcare Conference. It's our last session of the conference, but I always like to say, save the best for last. I've got the pleasure of hosting a fireside chat today with TG Therapeutics. And with me, joining from the company is Michael Weiss. He's Chief Executive Officer.

And so maybe before we get into detailed questions about the company, Michael, you and I have known each other for quite some time. You've helped cofound the company, actually, back in 2011, and we met sometime in 2013 or maybe 2014.

So as we find ourselves here in mid-2020, maybe if you could start off by providing some reflections of kind of the vision for the company as you cofounded it, and where you've come -- from there, where you are now. So I'll turn it to you.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot